ISSN 2147-9720 | E-ISSN 2148-4279
Original Article
Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: original article
1 Department of Pediatrics, Division of Pediatric Immunology and Allergy, Cumhuriyet University Faculty of Medicine, Sivas, Turkey  
2 Department of Pediatrics, Division of Pediatric Nefrology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey  
3 Department of Pediatrics, Cumhuriyet University Faculty of Medicine, Sivas, Turkey  
Eur J Rheumatol 2015; 2: 20-23
DOI: 10.5152/eurjrheumatol.2015.0093
This article was viewed 1156 times, downloaded 370 times

Key Words: Children, familial Mediterranean fever, mutation, neutrophil, lymphocyte
Abstract

Objective: The aim of present study was (a) to evaluate the relationship between the neutrophil/lymphocyte (N/L) ratio and mutation types of familial Mediterranean fever (FMF) in children and (b) to evaluate the relationship between the N/L ratio and age.

 

Material and Methods: Three hundred forty-three children with familial Mediterranean fever in the attack-free period and 283 healthy control children were included in the study. Patients were divided into subgroups according to mutation types. Neutrophil and lymphocyte counts were retrieved from medical records of patients and the N/L ratio was calculated from these parameters.

 

Results: The N/L ratio of patients was found to be significantly higher than that of controls (p<0.001). Among 343 patients, homozygous, heterozygous, and compound mutations were observed in 39, 253, and 51 patients, respectively. The differences in the N/L ratio among patients with homozygous, heterozygous, and compound mutations were not statistically significant. The most common mutations were M694V (n=126), E148Q (n=70), M680I, (n=33), and V726A (n=28). Significant differences were not observed among these mutations in terms of the N/L ratio (p>0.05). In all subjects, there was a weak but significant relationship between age and the N/L ratio (r: 0.215, p<0.001).

 

Conclusion: The N/L ratio, which can be determined by simple methods in routine blood tests,  may be used for the follow-up monitoring of chronic inflammation in patients. In addition, the N/L ratio may give an idea to clinicians regarding the early initiation of treatment in patients with typical clinical findings of FMF.

 

Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2017 Medical Research and Education Association | Latest Update: 15.09.2017